TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway

被引：0
|
作者：
Ying Xing
Yuechao Liu
Tianbo Liu
Qingwei Meng
Hailing Lu
Wei Liu
Jing Hu
Chunhong Li
Mengru Cao
Shi Yan
Jian Huang
Ting Wang
Li Cai
机构：
[1] Harbin Medical University Cancer Hospital,The Fourth Department of Medical Oncology
[2] Harbin Medical University Cancer Hospital,Department of Gynecology
[3] Harbin Medical University,The Sixth Department of Medical Oncology
[4] Harbin Medical University Cancer Hospital,undefined
来源：
Cell Communication and Signaling | / 16卷
关键词：
TNFAIP8; NSCLC; Proliferation; Cisplatin chemoresistance; MDM2/p53 pathway;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Knockdown of GINS2 inhibits proliferation and promotes apoptosis through the p53/GADD45A pathway in non-small-cell lung cancer
    Chi, Feng
    Wang, Zhou
    Li, Yuzhu
    Chang, Ning
    BIOSCIENCE REPORTS, 2020, 40
  • [32] Adverse prognostic significance of TNFAIP8 protein expression in non small cell lung cancer
    Kallakury, Bhaskar V.
    Kasid, Usha N.
    Voronel, Olga
    Sheehan, Christopher B.
    Sheehan, Christine E.
    Ross, Jeffrey S.
    CANCER RESEARCH, 2014, 74 (19)
  • [33] p53 and MDM2 in germ cell cancer treatment response
    Oliver, RTD
    Shamash, J
    Berney, DM
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (18) : 3928 - 3928
  • [34] Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice
    Jung, Cho-Rok
    Lim, Jung Hwa
    Choi, Yoonjung
    Kim, Dae-Ghon
    Kang, Koo Jeong
    Noh, Seung-Moo
    Im, Dong-Soo
    JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (12): : 4493 - 4506
  • [35] Tryptanthrin reduces mast cell proliferation promoted by TSLP through modulation of MDM2 and p53
    Han, Na-Ra
    Kim, Hyung-Min
    Jeong, Hyun-Ja
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 79 : 71 - 77
  • [36] The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer
    Kawasaki, M
    Nakanishi, Y
    Kuwano, K
    Yatsunami, J
    Takayama, K
    Hara, N
    CLINICAL CANCER RESEARCH, 1997, 3 (07) : 1195 - 1200
  • [37] p53 and MDM2 isoforms in blood from lung cancer patients
    Gonzalez-Avila, Georgina
    Biol, Javier Delgado
    Martinez, Luis M.
    Ramos, Carlos
    Sommer, Bettina
    EXPERIMENTAL LUNG RESEARCH, 2007, 33 (05) : 245 - 258
  • [38] In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
    Vassilev, LT
    Vu, BT
    Graves, B
    Carvajal, D
    Podlaski, F
    Filipovic, Z
    Kong, N
    Kammlott, U
    Lukacs, C
    Klein, C
    Fotouhi, N
    Liu, EA
    SCIENCE, 2004, 303 (5659) : 844 - 848
  • [39] PTEN/pAkt/p53 signaling pathway correlates with the radioresponse of non-small cell lung cancer
    Jung, Il Lae
    Kang, Hyo Jin
    Kim, Kug Chan
    Kim, In Gyu
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 25 (04) : 517 - 523
  • [40] Clinical significance of mdm2 and p53 expression in bladder cancer - A comparison with cell proliferation and apoptosis
    Shiina, H
    Igawa, M
    Shigeno, K
    Yamasaki, Y
    Urakami, S
    Yoneda, T
    Wada, Y
    Honda, S
    Nagasaki, M
    ONCOLOGY, 1999, 56 (03) : 239 - 247
12345